Delivery Order SPE2DB22D2007-SPE2DB24FH9XF
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 400 mg vials of the pharmaceutical product BENLYSTA. The delivery order, valued at $1,259.50, has a completion date of March 19, 2024 and was awarded on February 27, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00, through December 31, 2025, which serves...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 400 mg vials of the specialty pharmaceutical drug BENLYSTA. The $1,259.50 contract has a completion date of February 26, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under an indefinite delivery contract (IDC) with a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $1,259.50 order is for 400 milligram vials of the medication Benlysta. The delivery order has a completion date of February 26, 2024 and was awarded on February 2, 2024. No set-aside designations were used for this contract. Amerisourcebergen Drug Corporation has an indefinite...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,259.50 order is for the supply of 400 mg vials of the pharmaceutical product BENLYSTA. The order has a completion date of January 25, 2024. Amerisourcebergen Drug Corp, as a prime contractor, has previously received numerous federal contract awards from DLA to provide pharmaceuticals, medical supplies, and related...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The order is for the supply of BENLYSTA 400 MG vials, a specialty pharmaceutical product, with a potential value of $1,259.50 and a completion date of March 21, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 400 mg vials of the pharmaceutical product BENLYSTA. The $1,259.50 order has a completion date of March 12, 2024 and was awarded on February 20, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 400 mg vials of the pharmaceutical product BENLYSTA. The contract has a period of performance through January 25, 2024 and a potential value of $1,259.50. No set-aside designation was used. Amerisourcebergen Drug Corp is a prime contractor that has received numerous awards from DLA Troop Support Medical to supply...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the for-profit pharmaceutical distribution company Amerisourcebergen Corporation, to supply 400 mg vials of the specialty biologic medication BENLYSTA. The $7,557.00 delivery order has a completion date of March 13, 2024 and was awarded on February 21, 2024. This order is part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued up to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide BENLYSTA 400 MG vials. The contract has a ceiling value of $1,259.50 and a period of performance through April 22, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a potential value of up to $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $4,550.40 to AmerisourceBergen Drug Corp, a for-profit organization, to provide 120 mg vials of the pharmaceutical product BENLYSTA. The delivery order has a completion date of February 26, 2024 and was awarded on February 2, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, serves as the prime contractor for this contract, which is not...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FH9XFDelivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 400 mg vials of the pharmaceutical drug BENLYSTA. The order has a completion date of March 18, 2024 and a potential value of $1,259.50. Amerisourcebergen Drug Corp is a prime contractor for DLA, providing a wide range of pharmaceutical products and medical supplies to support military treatment programs and facilities. This delivery order is issued under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, allowing Amerisourcebergen to deliver a comprehensive range of medications and healthcare materials to DLA Troop Support Medical facilities. No set-aside designation was used for this contract award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 2/26/24 |